Ana Lourdes Luis

Dr. Ana Lourdes Luis

Pediatric Surgery, Hospital Infantil Universitario Niño Jesús, Madrid, Spain
orcid
Dr. Ana Lourdes Luis

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2006 in Pediatric Surgery International
Verified
Journal Article
Closed access
PDF file
FMFrancesca Martino
Francesca Martino
LALuis F. Avila
Luis F. Avila
JEJose L. Encinas
Jose L. Encinas
Ana Lourdes LuisAna Lourdes Luis
Ana Lourdes Luis
POPedro Olivares
Pedro Olivares
JTJuan A. Tovar
Juan A. Tovar

1 February 2007 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
JTJuan A. Tovar
Juan A. Tovar
Ana Lourdes LuisAna Lourdes Luis
Ana Lourdes Luis
JEJose L. Encinas
Jose L. Encinas
LBLaura Burgos
Laura Burgos
FPFederica Pederiva
Federica Pederiva
POPedro Olivares
Pedro Olivares

14 November 2008 in European Journal of Pediatric Surgery
Verified
Journal Article
Closed access
PDF file
SBS. Barrena
S. Barrena
AAA. M. Andres
A. M. Andres
LBL. Burgos
L. Burgos
Ana Lourdes LuisAna Lourdes Luis
Ana Lourdes Luis
FHFrancisco Hernandez
Francisco Hernandez
JTJ. A. Tovar
J. A. Tovar
Aim: Aim of this study was to assess the long-term results of the treatment of total colonic aganglionosis (TCA) with 2 different techniques in terms of growth, continence and quality of life (QOL). Patients and Methods: Forty-one patients treated for TCA between 1972 and 2007 were reviewed retrospectively with special attention paid to the length of aganglionosis, complications, growth, continence and QOL. Until 1992, patients underwent subtotal colonic resection and side-to-side ileosigmoid anastomosis (modified Martin). Since 1992, straight ileo-anal pull-through was preferred. At the end of follow-up (median 18 years, range 1–35), the height and weight, continence and QOL (scoring feeding habits, school/work performance, family life and professional development) were assessed by clinical visit or phone interview. Results: Twenty-eight patients were male and 13 female. Six had total intestinal aganglionosis and were excluded from this review together with the 2 who died before definitive treatment. The 33/41 persons in whom aganglionosis had involved less than 50 cm above the ileocecal valve and who had been considered suitable for the reestablishment of transanal fecal flow were included. Eighteen children underwent a modified Martin and 15 straight ileo-anal pull-through. Postoperative intestinal obstruction occurred in 4 cases, prolapse and prolonged TPN requirement in 2, and wound disruption and fistula in 1. Thirteen patients (39 %) had postoperative enterocolitis. Two children died after operation (1 wound disruption with sepsis and 1 pneumonia). Out of 31 survivors, 57 % and 53 % were > p50 with regard to height and weight whereas only 15 % and 19 % were <p3 respectively. Only half the patients had more than 3 bowel movements per day and the median Wildhaber continence score (normal = 14) was 11 (range 6–14). Both types of operations resulted in comparable defecation and continence patterns. QOL was rated as good in all cases but one. All patients but 2 attended high school, 8 attend university, 4 are employed and 1 is married and has 2 daughters. Social life is normal except for 1 patient who perceives his disease as a burden. Conclusions: Patients with TCA amenable to reestablishment of the transanal fecal flow can have adequate growth, normal feeding, reasonably good continence and satisfactory QOL. However, complications and enterocolitis are frequent. A modified Martin's procedure was performed as well as straight ileo-anal pull-through with little influence on the long-term outcome.

30 November 2005 in Pediatric Surgery International
Verified
Journal Article
Closed access
PDF file
JEJ. L. Encinas
J. L. Encinas
Ana Lourdes LuisAna Lourdes Luis
Ana Lourdes Luis
LAL. F. Avila
L. F. Avila
LML. Martinez
L. Martinez
LGLuis Garcia-Gueretaa
Luis Garcia-Gueretaa
JTJuan A. Tovar
Juan A. Tovar

18 November 2023 in Cancers
Verified
Journal Article
Open access
PDF file
JLJean François Lecompte
Jean François Lecompte
SSSabine Sarnacki
Sabine Sarnacki
SISabine Irtan
Sabine Irtan
CPChristian Piolat
Christian Piolat
ASAurélien Scalabre
Aurélien Scalabre
Florent GuérinFlorent Guérin
Florent Guérin
Objectives: To assess the efficacy of thoracoscopy and the outcome for children with thoracic neurogenic tumors. Methods: We performed a retrospective review of 15 European centers between 2000 and 2020 with patients who underwent thoracoscopy for a neurogenic mediastinal tumor. We assessed preoperative data, complications, and outcomes. Results were expressed with the median and range values. Results: We identified 119 patients with a median age of 4 years old (3 months–17 years). The diameter was 5.7 cm (1.1–15). INRG stage was L1 n = 46, L2 n = 56, MS n = 5, M n = 12. Of 69 patients with image-defined risk factors (IDRF), 29 had only (T9–T12) locations. Twenty-three out of 34 patients with preoperative chemotherapy had an 18 mm (7–24) decrease in diameter. Seven out of 31 patients lost their IDRF after chemotherapy. Fourteen had a conversion to thoracotomy. The length of the hospital stay was 4 days (0–46). The main complications included chylothorax (n = 7) and pneumothorax (n = 5). Long-term complications included Horner’s syndrome (n = 5), back pain, and scoliosis (n = 5). Pathology was 53 neuroblastomas, 36 ganglioneuromas, and 30 ganglioneuroblastomas. Fourteen had a postoperative residue. With a median follow-up of 21 months (4–195), 9 patients had a recurrence, and 5 died of disease. Relapses were associated with tumor biology, histology, and the need for chemotherapy (p = 0.034, <0.001, and 0.015, respectively). Residues were associated with preoperative IDRF (excluding T9–T12 only) and the need for preoperative chemotherapy (p = 0.04 and 0.020). Conclusion: Our results show that thoracoscopy is safe, with good outcomes for thoracic neurogenic tumors in selected cases. Surgical outcomes are related to the IDRFs, whereas oncologic outcomes are related to tumor histology and biology.

31 May 2024 in Journal of Pediatric Surgery Open
Verified
Journal Article
Open access
CGCristina Garcés-Visier
Cristina Garcés-Visier
PMPrzemyslaw Maruszewski
Przemyslaw Maruszewski
Ana Lourdes LuisAna Lourdes Luis
Ana Lourdes Luis
PBPedro Borrrego-Jimenez
Pedro Borrrego-Jimenez
DADaniel Azorín
Daniel Azorín
JAJose Lorenzo Alonso-Calderón
Jose Lorenzo Alonso-Calderón